John Roswech
First SEC filing: Dec. 18, 2019 · Latest: Dec. 18, 2019
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 3, 2022 | MCHX | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 3, 2022 | MCHX | A | 50,000 | $0.01 | $500 | 375,000 Direct | +15.38% | Acquired | 12800.0% (price as of 2026-10-02) |
| Jan. 4, 2021 | MCHX | A | 35,000 | · | · | 35,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 4, 2021 | MCHX | A | 35,000 | $0.01 | $350 | 325,000 Direct | +12.07% | Acquired | 12800.0% (price as of 2026-10-02) |
| April 22, 2020 | MCHX | P 10b5-1 | 2,500 | $1.36 | $3,400 | 290,000 Direct | +0.87% | Acquired | -5.1% (price as of 2026-10-02) |
| April 15, 2020 | MCHX | P 10b5-1 | 2,500 | $1.49 | $3,725 | 287,500 Direct | +0.88% | Acquired | -13.4% (price as of 2026-10-02) |
| April 8, 2020 | MCHX | P 10b5-1 | 2,500 | $1.33 | $3,325 | 285,000 Direct | +0.88% | Acquired | -3.0% (price as of 2026-10-02) |
| April 1, 2020 | MCHX | P 10b5-1 | 2,500 | $1.42 | $3,550 | 282,500 Direct | +0.89% | Acquired | -9.2% (price as of 2026-10-02) |
| Dec. 16, 2019 | MCHX | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2019 | MCHX | A | 80,000 | $0.01 | $800 | 80,000 Direct | · | Acquired | 12800.0% (price as of 2026-10-02) |
| Dec. 16, 2019 | MCHX | A | 200,000 | $0.01 | $2,000 | 200,000 Direct | · | Acquired | 12800.0% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 3, 2022 | MCHX | Employee Stock Option (right to buy) | Class B Common Stock | $2.56 | Jan. 3, 2032 | 50,000 | Acquired |
| Jan. 4, 2021 | MCHX | Employee Stock Option (right to buy) | Class B Common Stock | $2.02 | Jan. 4, 2031 | 35,000 | Acquired |
| Dec. 16, 2019 | MCHX | Employee Stock Option (right to buy) | Class B Common Stock | $3.60 | Dec. 16, 2029 | 200,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $53,255 | $45,139 | · | · | · | · | $15,000 | $113,394 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.